GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer
World J Clin Oncol; 13 (4), 2022
Non-small cell lung cancer (NSCLC) is a heterogeneous disease accounting for approximately 85% of all lung cancers. Only 17% of patients are diagnosed at an early stage. Treatment is multidisciplinary and radiotherapy plays a key role in all stages of the disease. More than 50% of patients with NSCLC are...